Evaluation of Dose-Titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

This study has been completed.

Study NCT00042458 Information provided by Amylin Pharmaceuticals, Inc.

First Received: July 30, 2002 Last Updated: November 5, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given